The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making

Question The optimal PSA-density thresholds for biopsy decisions in PI-RADS 1-3 patients remain uncertain, and data on the impact of prostate volume on its performance are limited. Findings Optimal PSA-density thresholds were 0.20 ng/mL² for PI-RADS 1-2 and 0.12 ng/mL² for PI-RADS 3. Diagnostic performance of PSA-density decreased significantly in men with larger glands (≥ 60 mL). Clinical relevance PSA-density cut-offs of 0.20 (PI-RADS 1-2) and 0.12 ng/mL² (PI-RADS 3) can guide biopsy decisions. In PI-RADS 1-3 patients with large prostate (≥ 60 mL), PSA-density becomes significantly less predictive, and low values may not reliably exclude csPCa.

Authors

Institutions

Publication Details

Journal
European Radiology
Published
2026-01-04
DOI
https://doi.org/10.1007/s00330-025-12272-y
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making

Kang-Lung Lee, Selahattin Durmaz, Tristan Barrett, Shun-Chin Jim Wu et al.
European Radiology
Prostate Cancer Diagnosis and Treatment
article

The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making

Kang-Lung Lee, Selahattin Durmaz, Tristan Barrett, Shun-Chin Jim Wu, Amreen Shakur, Iztok Caglič
article en

Abstract

Question The optimal PSA-density thresholds for biopsy decisions in PI-RADS 1-3 patients remain uncertain, and data on the impact of prostate volume on its performance are limited. Findings Optimal PSA-density thresholds were 0.20 ng/mL² for PI-RADS 1-2 and 0.12 ng/mL² for PI-RADS 3. Diagnostic performance of PSA-density decreased significantly in men with larger glands (≥ 60 mL). Clinical relevance PSA-density cut-offs of 0.20 (PI-RADS 1-2) and 0.12 ng/mL² (PI-RADS 3) can guide biopsy decisions. In PI-RADS 1-3 patients with large prostate (≥ 60 mL), PSA-density becomes significantly less predictive, and low values may not reliably exclude csPCa.

European Radiology
National Yang Ming Chiao Tung University (TW), University of Cambridge (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Taipei Veterans General Hospital (TW), Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi (TR), Addenbrooke's Hospital (GB), University College London (GB)
Cancer Research UK, Engineering and Physical Sciences Research Council, NIHR Cambridge Biomedical Research Centre
Peace, Justice and strong institutions
Openalex Percentile: Top 98%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making — Kang-Lung Lee, Selahattin Durmaz, et al. · European Radiology (2026) | TGRS Research Map | TGRS